Tirzepatide is a GIP/GLP-1 receptor agonist used in FDA-approved prescription products for specific indications. Approved Mounjaro or Zepbound products should not be conflated with compounded or unverified products marketed using the ingredient name.
Tirzepatide at a glance
| Brand names | Mounjaro, Zepbound |
|---|---|
| Class | GIP and GLP-1 receptor agonist |
| U.S. status | FDA-approved products exist for defined indications |
| Evidence | Substantial human evidence for approved uses |
| Reviewed | August 11, 2026 |
How is tirzepatide different from semaglutide?
Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide activates GLP-1 receptors. That difference does not determine which product is appropriate for an individual. Comparisons require indication-specific trials, current labels, and relevant head-to-head evidence.
What does human research show?
Randomized trials support meaningful glycemic and weight-related improvements in studied populations, leading to FDA approvals under separate product labels. Group averages do not predict individual response or eliminate adverse-effect and contraindication concerns.
Risks and label warnings
The current Zepbound label includes a boxed warning concerning thyroid C-cell tumors observed in rats; whether tirzepatide causes such tumors in humans is unknown. It also contains contraindications and warnings involving gastrointestinal reactions and other clinically important risks. Readers should consult current product-specific labeling.
Compounded and unverified products
Compounded tirzepatide is not FDA-approved. FDA has acted against claims implying non-approved compounded GLP-1 products are the same as approved medicines. Identity, quality, storage, and labeling can materially affect risk.
What people report online
Community-reported—not proof: themes include appetite, gastrointestinal experiences, weight trajectories, access, cost, plateaus, and switching. Posts rarely provide enough verified information to establish causation or comparative effectiveness.
Frequently asked questions
Are Mounjaro and Zepbound the same thing?
They contain tirzepatide but are distinct FDA-approved products with their own labeling and indications. A shared ingredient does not make every claim or use interchangeable.
Primary sources
- DailyMed: Current Zepbound prescribing information
- FDA Label database: Zepbound
- FDA: Non-FDA-approved GLP-1 products
Educational information only; not individualized medical advice or treatment instruction.
Leave a Reply